Atomi Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-31,909
Closed -$918K – 795
2024
Q1
$918K Sell
31,909
-71
-0.2% -$2.13K 0.08% 196
2023
Q4
$1.05M Buy
31,980
+2,932
+10% +$79.7K 0.15% 128
2023
Q3
$809K Buy
+29,048
New +$950K 0.27% 95

Other funds holding ARKG

Atomi Financial Group's ARKG Position: Q2 2024 in Review

Atomi Financial Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 31,909 shares — an estimated $918K sold.

Atomi Financial Group first reported a position in ARKG in Q3 2023 and held it in 3 quarters. The position peaked at $1.05M in Q4 2023. 263 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Atomi Financial Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Atomi Financial Group sold 31,909 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $918K.
  • Atomi Financial Group first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 3 quarters.
  • Atomi Financial Group's ARK Genomic Revolution ETF position peaked at $1.05M in Q4 2023.
  • 263 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Atomi Financial Group's 13F filing for Q2 2024, filed 26 Jul 2024.